Front. Endocrinol. Frontiers in Endocrinology Front. Endocrinol. 1664-2392 Frontiers Media S.A. 10.3389/fendo.2023.1221004 Endocrinology Correction Corrigendum: Incorporation size of lymph node metastasis focus and pre-ablation stimulated Tg could more effectively predict clinical outcomes in differentiated thyroid cancer patients without distant metastases Xie Jiahao † Chen Pan † Wang Jing † Luo Xiaoqin Luo Jiaxin Xiong Xiaoli Li Chunyan Pan Liqin Wu Juqing Feng Huijuan Ouyang Wei * Department of Nuclear Medicine, The Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Wei Ouyang, oyw1963@sina.com

†These authors have contributed equally to this work and share first authorship

 14 07 2023 2023 14 1221004 11 05 2023 27 06 2023 Copyright © 2023 Xie, Chen, Wang, Luo, Luo, Xiong, Li, Pan, Wu, Feng and Ouyang 2023 Xie, Chen, Wang, Luo, Luo, Xiong, Li, Pan, Wu, Feng and Ouyang

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Incorporation size of lymph node metastasis focus and pre-ablation stimulated Tg could more effectively predict clinical outcomes in differentiated thyroid cancer patients without distant metastases by Xie J, Chen P, Wang J, Luo X, Luo J, Xiong X, Li C, Pan L, Wu J, Feng H and Ouyang W (2023) Front. Endocrinol. 14:1094339. doi: 10.3389/fendo.2023.1094339 differentiated thyroid cancer lymph node metastasis pre-ablation stimulated Tg 131I therapy prognosis section-in-acceptance Cancer Endocrinology

In the published article, there was an error in Figure 3 as published. The third legend in Figure 3C incorrectly stated “size of the largest metastatic LN>0.4cm”. The corrected Figure 3 and its caption appear below.

(A) The X-tile software of size of the largest metastatic LN for the prediction of persistent/recurrent disease vs long-term remission. (B) Patient frequency according to the size of the largest metastatic LN (the optimal cutoffs were 0.4cm and 1.4cm); (C) Kaplan Meier survival curves for different risk groups (P < 0.001).

In the published article, there was an error. The decimals in Tg cutoff values were incorrect throughout the text. Instead of “10.0”, it should be “10.1”.

The authors apologize for these errors and state that these do not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.